Axalta Coating Systems earnings beat by $0.02, revenue fell short of estimates

Axalta Coating Systems (AXTA) reported mixed second-quarter results, with EPS of $0.64 exceeding the $0.62 consensus but revenue of $1.3 billion missing the $1.32 billion estimate. The company's Q3 EPS and full-year revenue guidance also largely fell below analyst expectations, while full-year EPS guidance was in line. This cautious outlook, coupled with 15 negative EPS revisions in the past 90 days and a stock price down nearly 20% over the last year, suggests continued investor caution despite the Q2 EPS beat.

Analysis

Axalta Coating Systems (AXTA) presented mixed second-quarter results, characterized by a marginal earnings beat offset by a revenue shortfall and a cautious forward outlook. The company reported Q2 EPS of $0.64, exceeding the analyst consensus by $0.02, but its revenue of $1.3 billion fell short of the $1.32 billion estimate. This top-line weakness extends into the company's guidance, with its Q3 2025 EPS forecast of $0.63-$0.67 and full-year 2025 revenue forecast of $5.20B-$5.27B both trailing consensus estimates. While the full-year EPS guidance of $2.45-$2.55 brackets the $2.50 consensus, this appears to be predicated on margin performance rather than growth. The prevailing negative sentiment is further evidenced by 15 negative EPS revisions versus only one positive revision in the last 90 days. This fundamental picture is reflected in the stock's performance, which has declined 13.45% in the last three months and 19.50% over the past year, indicating that investor concerns about growth and profitability predate this report and are unlikely to be assuaged by these results.

Key Decisions for Investors

• Investors should view the narrow Q2 EPS beat with caution, as it is overshadowed by a revenue miss and a weak top-line forecast for the remainder of fiscal year 2025.
• Given the significant stock underperformance of -19.50% over the last 12 months and a wave of 15 negative EPS revisions, the current guidance provides little catalyst for a positive re-rating.
• Monitor for any further downward revisions to revenue or signs of margin compression, as the in-line full-year EPS guidance appears vulnerable to the projected top-line softness.